tetradecanoylphorbol acetate has been researched along with protectin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boussetta, T; Driss, F; El-Benna, J; Fay, M; Guichardant, M; Lagarde, M; Liu, M; Makni-Maalej, K | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and protectin d1
Article | Year |
---|---|
Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities.
Topics: Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Humans; Immunoblotting; Isomerism; Lipopolysaccharides; Lipoxygenase; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; Peroxidase; Phosphorylation; Prostaglandins; Reactive Oxygen Species; Serine; Superoxides; Tetradecanoylphorbol Acetate; Time Factors | 2014 |